Form 4: Alphatec Director Karen McGinnis Reports Stock Transactions

Director Karen McGinnis acquired 32,012 restricted stock units and sold 6,050 shares to cover tax obligations.

Summary

• Director Karen McGinnis received a grant of 32,012 restricted stock units (RSUs) on June 10, 2026.
• The RSUs vest on the earlier of the next annual meeting or the director's death or resignation.
• The director sold 6,050 shares of common stock on June 11, 2026, at a price of $8.01 per share.
• The sale was executed under a pre-established Rule 10b5-1 trading plan to cover tax withholding obligations.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions are routine administrative actions related to compensation and tax obligations.

Positives

• Director maintains a significant equity stake of 94,671 shares following the transactions.

Negatives

• The sale of 6,050 shares reduces the director's direct holdings.

Risks

• Future vesting of equity is subject to the director's continued service or specific termination conditions.

Future Outlook

The filing does not provide forward-looking financial guidance for the company.

Industry Context

StockSavvy.ai notes that routine insider transactions, particularly those executed under Rule 10b5-1 plans for tax purposes, are standard corporate governance practices and generally do not signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans for tax withholding is a standard practice among directors of publicly traded medical device companies to ensure compliance and avoid potential conflicts of interest.

Stakeholder Impact

• Minimal impact on shareholders as the sale was pre-planned and limited to tax obligations.

Next Steps

• Vesting of restricted stock units at the next annual meeting of stockholders.

Key Dates

Keywords

Alphatec Holdings, ATEC, Insider Trading, Form 4, Restricted Stock Units, Rule 10b5-1